Is Proto Labs (PRLB) Trading Margin for Growth With Its Latest Earnings Guidance?

• Proto Labs, Inc. recently announced its second quarter 2025 earnings, reporting sales of US$135.06 million versus US$125.52 million a year earlier, and provided earnings guidance for the third quarter with expected revenue between US$130.0 million and US$138.0 million.
• While sales increased year-over-year, net income for both the quarter and the first half was slightly lower compared to the same period last year, highlighting ongoing margin pressures even as the company moves forward with new guidance.
• We'll examine how the higher second quarter revenue and updated earnings guidance affect Proto Labs' broader investment narrative.

Outshine the giants: these 19 early-stage AI stocks could fund your retirement.

Proto Labs Investment Narrative Recap

Proto Labs appeals to investors who see long-term value in digital manufacturing driven by automation and customization, particularly as demand from sectors like Aerospace and Defense grows. The latest earnings indicate steady sales momentum, but margin pressures and slightly lower net income remain unresolved, so for now, neither the short-term catalyst of expanding specialized manufacturing nor the risk of customer concentration have materially shifted.

Among recent announcements, the company’s updated guidance for third quarter 2025, projecting revenue between US$130.0 million and US$138.0 million and diluted EPS of US$0.17 to US$0.25, is most directly relevant. These forecasts provide a window into management’s expectations as Proto Labs continues to contend with margin headwinds and shifts in end-market demand, key concerns for those tracking near-term performance. Contrast this outlook, however, with the persistent risk investors should be aware of: ongoing margin compression and Proto Labs’ ability to ...

Read the full narrative on Proto Labs (it's free!)

Proto Labs' outlook anticipates $592.3 million in revenue and $33.7 million in earnings by 2028. This scenario is based on an expected 5.2% annual revenue growth and a $18.9 million increase in earnings from the current level of $14.8 million.

Uncover how Proto Labs' forecasts yield a $50.00 fair value, a 11% upside to its current price.

Exploring Other Perspectives

Simply Wall St Community members estimate fair value for Proto Labs between US$35.25 and US$50 across 2 different perspectives. With margin pressures still a concern after recent earnings, it’s clear that investor opinions can widely differ and you may want to compare a range of views yourself.

Explore 2 other fair value estimates on Proto Labs - why the stock might be worth 22% less than the current price!

Build Your Own Proto Labs Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Proto Labs research is our analysis highlighting 1 key reward and 2 important warning signs that could impact your investment decision.
• Our free Proto Labs research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Proto Labs' overall financial health at a glance.

Looking For Alternative Opportunities?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• AI is about to change healthcare. These 26 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• These 19 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
• Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com